Keith L Brownlie Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Keith L Brownlie.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Keith L Brownlie. Keith L Brownlie is a Director in Celldex Therapeutics, Inc. ($AVAN) and a Director in SOLIGENIX, INC. ($DOR) and a Director in IMMUNE PHARMACEUTICALS INC ($IMNP) and a Director in RXi Pharmaceuticals Corp ($RXII).

Address: 777 OLD SAW MILL RIVER RD TARRYTOWN 10591 NY

Companies in which Keith L Brownlie is an Insider

Celldex Therapeutics, Inc.

Trading Symbol: CLDX
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Keith L Brownlie: Director
Holdings: 10,000 shares
Latest Transaction: Jun 19 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

IMMUNE PHARMACEUTICALS INC

Trading Symbol: IMNP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith L Brownlie: Director
Holdings: 360,000 shares
Current Value: $68,400
Latest Transaction: Aug 14 2013
$IMNP Market Capitalization: $23.82M
$IMNP Previous Close: $0.19

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Phio Pharmaceuticals Corp.

Trading Symbol: PHIO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith L Brownlie: Director
Holdings: 20,000 shares
Current Value: $12,800
Latest Transaction: Feb 15 2019
$PHIO Market Capitalization: $4.88M
$PHIO Previous Close: $0.64

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

SOLIGENIX, INC.

Trading Symbol: SNGX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith L Brownlie: Director
Holdings: 50,000 shares
Latest Transaction: Sep 28 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Keith L Brownlie

Sentiment: All, CLDX, IMNP, PHIO, SNGX

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 19 2020AVANCelldex Therapeuti ...Brownlie Keith LDirectorOption ExerciseA10.3811,000114,18011,000
Jun 20 2019AVANCelldex Therapeuti ...Brownlie Keith LDirectorOption ExerciseA2.784,50012,5104,500
Feb 15 2019RXIIPhio Pharmaceutica ...Brownlie Keith LDirectorGrantA0.0010,000020,00010 K to 20 K (+100.00 %)
Sep 28 2018SNGXSOLIGENIX, INC.Brownlie Keith LDirectorOption ExerciseA1.6717,96430,00017,964
Aug 03 2018RXIIRXi Pharmaceutical ...Brownlie Keith LDirectorGrantA0.0010,000010,0000 to 10 K
Jun 15 2018AVANCelldex Therapeuti ...Brownlie Keith LDirectorOption ExerciseA0.6067,00040,27467,000
Jun 16 2017AVANCelldex Therapeuti ...Brownlie Keith LDirectorOption ExerciseA2.328,00018,5608,000

View all Keith L Brownlie insider transactions.